Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion related macular oedema: A prospective randomized comparison—Response

Saved in:
Bibliographic Details
Published inClinical & experimental ophthalmology Vol. 47; no. 5; p. 687
Main Authors Macky, Tamer A., Gado, Ahmed S.
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.07.2019
Wiley Subscription Services, Inc
Subjects
Angiogenesis Inhibitors
Bevacizumab
Dexamethasone
Edema
Humans
Intravitreal Injections
Macular Edema
Monoclonal antibodies
Occlusion
Prospective Studies
Retina
Retinal Vein Occlusion
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1442-6404
1442-9071
DOI:10.1111/ceo.13490